Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
chung sun lin
(9 results)?
Effective clearance of rituximab-resistant tumor cells by breaking the mirror-symmetry of immunoglobulin G and simultaneous binding to CD55 and CD20.
Sci Rep. 2023 Oct 25;13(1):18275. doi: 10.1038/s41598-023-45491-8.
Sci Rep. 2023.
PMID: 37880350
Free PMC article.
A human antibody against human endothelin receptor type A that exhibits antitumor potency.
Ju MS, Ahn HM, Han SG, Ko S, Na JH, Jo M, Lim CS, Ko BJ, Yu YG, Lee WK, Kim YJ, Jung ST.
Ju MS, et al. Among authors: lim cs.
Exp Mol Med. 2021 Sep;53(9):1437-1448. doi: 10.1038/s12276-021-00678-9. Epub 2021 Sep 29.
Exp Mol Med. 2021.
PMID: 34588605
Free PMC article.
Item in Clipboard
Glycan-Controlled Human PD-1 Variants Displaying Broad-Spectrum High Binding to PD-1 Ligands Potentiate T Cell.
Ha JY, Chun KJ, Ko S, Lee HW, Hwang OK, Lim CS, Ha K, Ko BJ, Jung ST.
Ha JY, et al. Among authors: lim cs.
Mol Pharm. 2023 Apr 3;20(4):2170-2180. doi: 10.1021/acs.molpharmaceut.3c00003. Epub 2023 Mar 10.
Mol Pharm. 2023.
PMID: 36897183
Item in Clipboard
Optimal combination of beneficial mutations for improved ADCC effector function of aglycosylated antibodies.
Yoon HW, Jo M, Ko S, Kwon HS, Lim CS, Ko BJ, Lee JC, Jung ST.
Yoon HW, et al. Among authors: lim cs.
Mol Immunol. 2019 Oct;114:62-71. doi: 10.1016/j.molimm.2019.07.007. Epub 2019 Jul 20.
Mol Immunol. 2019.
PMID: 31336250
Item in Clipboard
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency.
Ko S, Ju MS, Ahn HM, Na JH, Ko WH, Jo M, Kyung M, Lim CS, Ko BJ, Lee WK, Kim YJ, Jung ST.
Ko S, et al. Among authors: lim cs.
Mol Pharm. 2023 Feb 6;20(2):1247-1255. doi: 10.1021/acs.molpharmaceut.2c00923. Epub 2022 Dec 23.
Mol Pharm. 2023.
PMID: 36563318
Item in Clipboard
Validation of Rapi-Fluor method for glycan profiling and application to commercial antibody drugs.
Lim MS, So MK, Lim CS, Song DH, Kim JW, Woo J, Ko BJ.
Lim MS, et al. Among authors: lim cs.
Talanta. 2019 Jun 1;198:105-110. doi: 10.1016/j.talanta.2019.01.093. Epub 2019 Jan 25.
Talanta. 2019.
PMID: 30876537
Item in Clipboard
Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries.
Kang K, Kim K, Lee SR, Kim Y, Lee JE, Lee YS, Lim JH, Lim CS, Kim YJ, Baek SI, Song DH, Hong JT, Kim DY.
Kang K, et al. Among authors: lim cs.
Int J Mol Sci. 2020 Sep 1;21(17):6354. doi: 10.3390/ijms21176354.
Int J Mol Sci. 2020.
PMID: 32883029
Free PMC article.
Item in Clipboard
Cite
Cite